CARMA FUND
Venture capitalMunich · Pre-Seed–Series A · 4 people tracked
Investment thesis
CARMA FUND I invests early in Life Science and Healthcare companies and projects, aiming to help translate scientific innovation toward market entry. It targets therapeutics, diagnostics, medical devices, and digital health, as well as R&D tools and platform technologies. The fund positions itself as an active partner offering an extra-long term horizon, flexible investment modes, and close relationships with technology transfer offices and industry partners. It sees Europe as home to a strong therapeutics industry with experienced entrepreneurs and leading scientists, and welcomes funding applications from all European sources, addressing the specialist capital needs of biotech and healthcare innovators.
Source: firm website, verified Aug 3, 2026.
Team · 4 people
from public directories
What they invest in
from 2 of 5 portfolio companiesDigital Health ×2Healthtech ×2Biotech ×1Data & Infrastructure ×1Deep Tech ×1Medical Devices ×1
HQs:Germany×2
Investments · 5 tracked
founders shown can be your intro pathA private biotech company developing crosslinked helix dimers as therapeutics targeting intracellular protein-protein interactions.
Dimericon Therapeutics is a biotech company developing crosslinked helix dimers ("Dimericons") as therapeutics and as templates for small-molecule development, targeting hard-to-drug intracellular protein-protein interactions.
BiotechDeep TechDigital HealthHealthtechMedical DevicesMunich, DE
Christian Leikert(Managing Partner)Dr. Martin Raditsch(Managing Partner)
Company developing novel TNF-targeting antibodies with selective epitope technology for improved therapeutic benefit-risk profiles and bispecific therapies.
Thryve provides a plug-and-play API platform that integrates health data from over 500 wearable devices and health ecosystems, harmonizing fragmented data into standardized insights for healthcare providers and digital health partners.
Data & InfrastructureDigital HealthHealthtechBerlin, DE
Frequently asked questions
- What stage does CARMA FUND invest at?
- CARMA FUND invests at the Pre-Seed, Seed, Series A stages.
- What sectors does CARMA FUND focus on?
- CARMA FUND focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is CARMA FUND located?
- CARMA FUND is headquartered in Munich, DE.
Images
.jpg)
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
Future Positive Capital's portfolio page showcasing companies across health, climate, and deeptech sectors.